E
EDWARDS LIFESCIENCES CORP
NYSE: EW (Edwards Lifesciences Corporatio)
Last update: yesterday, 2:33AM89.79
-0.04 (-0.04%)
| Previous Close | 89.83 |
| Open | 89.89 |
| Volume | 2,075,074 |
| Avg. Volume (3M) | 4,751,325 |
| Market Cap | 51,701,084,160 |
| Price / Earnings (TTM) | 53.45 |
| Price / Earnings (Forward) | 30.30 |
| Price / Sales | 8.11 |
| Price / Book | 4.93 |
| 52 Weeks Range | |
| Earnings Date | 29 Oct 2026 |
| Profit Margin | 75.71% |
| Operating Margin (TTM) | 29.01% |
| Diluted EPS (TTM) | 2.42 |
| Quarterly Revenue Growth (YOY) | 6.20% |
| Quarterly Earnings Growth (YOY) | 1.70% |
| Total Debt/Equity (MRQ) | 6.86% |
| Current Ratio (MRQ) | 4.45 |
| Operating Cash Flow (TTM) | 876.20 M |
| Levered Free Cash Flow (TTM) | 1.45 B |
| Return on Assets (TTM) | 8.42% |
| Return on Equity (TTM) | 16.51% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Mixed | |
| Stock | Edwards Lifesciences Corporatio | Mixed | Bullish |
AIStockmoo Score
-1.1
| Analyst Consensus | NA |
| Insider Activity | -1.5 |
| Price Volatility | -3.5 |
| Technical Moving Averages | -3.5 |
| Technical Oscillators | 4.0 |
| Average | -1.13 |
|
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Mid Growth |
| % Held by Insiders | 0.91% |
| % Held by Institutions | 89.29% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt | 30 Jun 2026 | 13,002,965 |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| LIPPIS DANIEL J. | - | 93.66 | -619 | -57,976 |
| Aggregate Net Quantity | -619 | |||
| Aggregate Net Value ($) | -57,976 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 93.66 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| LIPPIS DANIEL J. | Officer | 11 Aug 2026 | Automatic sell (-) | 619 | 93.66 | 57,976 |
| LIPPIS DANIEL J. | Officer | 11 Aug 2026 | Option execute | 619 | - | - |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |